Literature DB >> 2529314

Whole-blood lymphocyte cultures.

E Bloemena1, M T Roos, J L Van Heijst, J M Vossen, P T Schellekens.   

Abstract

A simple and reproducible method is described for the measurement of proliferative responses of peripheral blood lymphocytes in whole blood upon stimulation with horse anti-human lymphocyte serum (ALS), phytohaemagglutinin (PHA) or a monoclonal antibody (mAb) directed against CD3. Only small aliquots of blood are needed and separation procedures are not necessary. Since the method proved to be very reproducible and showed little variation, reference values of proliferation, expressed in cpm per 15 microliters blood and cpm per 10(3) CD3+ lymphocytes, were determined based upon the 5th and the 2.5th percentile of the distribution of the values in our reference population. In addition, the use of whole blood lymphocyte cultures in longitudinal studies of immunocompromised individuals is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529314     DOI: 10.1016/0022-1759(89)90260-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.

Authors:  H Choremi-Papadopoulou; N Panagiotou; E Samouilidou; F Kontopidou; V Viglis; A Antoniadou; J Kosmidis; T Kordossis
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Immune function in female elite rowers and non-athletes.

Authors:  D C Nieman; S L Nehlsen-Cannarella; O R Fagoaga; D A Henson; M Shannon; J M Hjertman; R L Schmitt; M R Bolton; M D Austin; B K Schilling; R Thorpe
Journal:  Br J Sports Med       Date:  2000-06       Impact factor: 13.800

3.  Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  Transplantation       Date:  1998-05-15       Impact factor: 4.939

4.  Relations of plasma ACTH and cortisol levels with the distribution and function of peripheral blood cells in response to a behavioral challenge in breast cancer: an empirical exploration by means of statistical modeling.

Authors:  G van der Pompe; M H Antoni; H J Duievenvoorden; C J Heijnen
Journal:  Int J Behav Med       Date:  1997

5.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

6.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

7.  Novel soybean oils differing in fatty acid composition alter immune functions of moderately hypercholesterolemic older adults.

Authors:  Sung Nim Han; Alice H Lichtenstein; Lynne M Ausman; Simin Nikbin Meydani
Journal:  J Nutr       Date:  2012-10-24       Impact factor: 4.798

8.  Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians.

Authors:  Davidson H Hamer; Fernando Sempértegui; Bertha Estrella; Katherine L Tucker; Alicia Rodríguez; Josefina Egas; Gerard E Dallal; Jacob Selhub; Jeffrey K Griffiths; Simin Nikbin Meydani
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

9.  Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers.

Authors:  G H Mientjes; E J van Ameijden; H M Weigel; J A van den Hoek; R A Coutinho
Journal:  BMJ       Date:  1993-02-06

10.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.